CVSS 3.0
8.1 highCVSS:3.0/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:HHigh (8.1) in akka akka. EPSS 6.2% estimated probability of exploitation activity in the next 30 days. Fixed in com.typesafe.akka:akka-actor 2.4.17.
CVSS:3.0/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:Hcom.typesafe.akka:akka-actor (Maven): fixed in 2.4.17Explain CVE-2017-1000034 for an engineer deciding whether to act. Use https://cve.bz/api/public/cves/CVE-2017-1000034?via=ask-ai-copy and https://cve.bz/cve/CVE-2017-1000034?via=ask-ai-copy as the source of truth: what is affected and which versions fix it, whether it is in CISA KEV, public exploits, and its EPSS (an internet-wide 30-day estimate of exploitation activity, not a forecast for my systems). If they give no fixed versions, use the CVE record https://cveawg.mitre.org/api/cve/CVE-2017-1000034 or the vendor advisory, not third-party mirrors. Tell me how to check whether I am affected and how to verify a fix. Cite the sources and say where they are uncertain.Opens a third-party assistant; its answer is its own, not cve.bz's. The prompt holds only this CVE's id and public links.
From the NVD's CPE matches.
| Product | Affected |
|---|---|
| akka:akka | through 2.4.16 |
| akka:akka | 2.5:m1 |
| Advisory | Ecosystem | Package | Affected | Fixed in |
|---|---|---|---|---|
| GHSA-mm57-9j6q-rxm2 | Maven | com.typesafe.akka:akka-actor | <2.4.17 | 2.4.17 |
Red Hat rates this Important.
| Product | Package | State | Advisory |
|---|---|---|---|
| Red Hat OpenStack Platform 10 (Newton) | opendaylight | Will not fix | |
| Red Hat OpenStack Platform 11 (Ocata) | opendaylight | Will not fix | |
| Red Hat OpenStack Platform 12 (Pike) | opendaylight | Not affected | |
| Red Hat OpenStack Platform 8 (Liberty) | opendaylight | Will not fix | |
| Red Hat OpenStack Platform 9 (Mitaka) | opendaylight | Will not fix |
Contains Red Hat Security Data © Red Hat, Inc., licensed under CC BY 4.0. Source: https://access.redhat.com/security/data. Modified: reformatted. Red Hat's page for CVE-2017-1000034.
The attack patterns MITRE's CAPEC relates to this record's weaknesses, as MITRE names them. Credits.